Literature DB >> 33361696

Preoperative Controlling Nutritional Status plus Tumor Burden Score for the Assessment of Prognosis after Curative Liver Resection for Hepatocellular Carcinoma.

Yasuyuki Fukami1, Takuya Saito2, Takaaki Osawa2, Takashi Arikawa2, Tatsuki Matsumura2, Shintaro Kurahashi2, Shunichiro Komatsu2, Kenitiro Kaneko2, Tsuyoshi Sano2.   

Abstract

OBJECTIVE: There are no previous studies analyzing the prognostic predictive value of adding the tumor factor (i.e., Tumor Burden (TB) score) to the Controlling Nutritional Status (CONUT) score for patients with hepatocellular carcinoma (HCC). This study aimed to investigate the value of the CONUT plus TB (CONUT-TB) score as a prognostic predictor in patients with HCC undergoing liver resection.
METHODS: Between 2015 and 2018, 96 consecutive patients with HCC underwent liver resection at our institution. Patients undergoing repeated liver resection and combined resection of a metastatic lesion were excluded. Patients were divided into 2 groups according to their CONUT-TB scores according to a cutoff value. Clinicopathologic prognostic factors for survival were analyzed using a database containing the medical records.
RESULTS: The optimal cutoff value of the CONUT-TB score determined by using a minimum p value approach was 13 points. Among the 81 patients included in the analytic cohort, 71 patients had low (<13) and 10 patients had high (>13) CONUT-TB scores. The overall 3-year survival rate of patients following liver resection for HCC in the high-CONUT-TB group was significantly worse than that of patients in the low-CONUT-TB group (62.5 vs. 89.3%, p = 0.003). Multivariate analysis indicated that a high CONUT-TB score was independently associated with overall survival after liver resection (p = 0.010).
CONCLUSION: The CONUT-TB score is a valuable predictor of survival in patients with HCC after liver resection.
© 2020 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Keywords:  Controlling Nutritional Status score; Hepatocellular carcinoma; Liver resection; Prognostic factor; Tumor burden score

Year:  2020        PMID: 33361696      PMCID: PMC8114066          DOI: 10.1159/000514031

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN: 1011-7571            Impact factor:   1.927


  26 in total

1.  Liver Resection for Multiple Hepatocellular Carcinomas: A Japanese Nationwide Survey.

Authors:  Yasuyuki Fukami; Yuji Kaneoka; Atsuyuki Maeda; Takashi Kumada; Junko Tanaka; Tomoyuki Akita; Shoji Kubo; Namiki Izumi; Masumi Kadoya; Michiie Sakamoto; Osamu Nakashima; Yutaka Matsuyama; Takashi Kokudo; Kiyoshi Hasegawa; Tatsuya Yamashita; Kosuke Kashiwabara; Tadatoshi Takayama; Norihiro Kokudo; Masatoshi Kudo
Journal:  Ann Surg       Date:  2020-07       Impact factor: 12.969

2.  Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma.

Authors:  Bo Hu; Xin-Rong Yang; Yang Xu; Yun-Fan Sun; Chao Sun; Wei Guo; Xin Zhang; Wei-Min Wang; Shuang-Jian Qiu; Jian Zhou; Jia Fan
Journal:  Clin Cancer Res       Date:  2014-09-30       Impact factor: 12.531

3.  Prognostic Significance of Preoperative Controlling Nutritional Status (CONUT) Score in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma.

Authors:  Norifumi Harimoto; Tomoharu Yoshizumi; Kazuhito Sakata; Akihisa Nagatsu; Takashi Motomura; Shinji Itoh; Noboru Harada; Toru Ikegami; Hideaki Uchiyama; Yuji Soejima; Yoshihiko Maehara
Journal:  World J Surg       Date:  2017-11       Impact factor: 3.352

4.  Prognosis of hepatocellular carcinoma: the BCLC staging classification.

Authors:  J M Llovet; C Brú; J Bruix
Journal:  Semin Liver Dis       Date:  1999       Impact factor: 6.115

5.  Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma.

Authors:  Jian-hong Zhong; Yang Ke; Wen-feng Gong; Bang-de Xiang; Liang Ma; Xin-ping Ye; Tao Peng; Gui-sheng Xie; Le-qun Li
Journal:  Ann Surg       Date:  2014-08       Impact factor: 12.969

6.  Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis.

Authors:  Vincenzo Mazzaferro; Josep M Llovet; Rosalba Miceli; Sherrie Bhoori; Marcello Schiavo; Luigi Mariani; Tiziana Camerini; Sasan Roayaie; Myron E Schwartz; Gian Luca Grazi; René Adam; Peter Neuhaus; Mauro Salizzoni; Jordi Bruix; Alejandro Forner; Luciano De Carlis; Umberto Cillo; Andrew K Burroughs; Roberto Troisi; Massimo Rossi; Giorgio E Gerunda; Jan Lerut; Jacques Belghiti; Ilka Boin; Jean Gugenheim; Fedja Rochling; Bart Van Hoek; Pietro Majno
Journal:  Lancet Oncol       Date:  2008-12-04       Impact factor: 41.316

Review 7.  Surgery for small liver cancers.

Authors:  M Makuuchi; T Kosuge; T Takayama; S Yamazaki; T Kakazu; S Miyagawa; S Kawasaki
Journal:  Semin Surg Oncol       Date:  1993 Jul-Aug

8.  Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan.

Authors:  Masatoshi Makuuchi; Norihiro Kokudo; Shigeki Arii; Shunji Futagawa; Shuichi Kaneko; Seiji Kawasaki; Yutaka Matsuyama; Masatoshi Okazaki; Kiwamu Okita; Masao Omata; Yukihisa Saida; Tadatoshi Takayama; Yoshio Yamaoka
Journal:  Hepatol Res       Date:  2008-01       Impact factor: 4.288

Review 9.  Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma.

Authors:  Jordi Bruix; Maria Reig; Morris Sherman
Journal:  Gastroenterology       Date:  2016-01-12       Impact factor: 22.682

10.  Body mass index and cholesterol level predict surgical outcome in patients with hepatocellular carcinoma in Taiwan - a cohort study.

Authors:  Ya-Ling Lee; Wan-Chun Li; Tung-Hu Tsai; Hsin-Yu Chiang; Chin-Tsung Ting
Journal:  Oncotarget       Date:  2016-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.